Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simula

Showing results (281-290 of 296) with videos related to

Pageof 30
Sort By:
Frontiers in Immunology|September 3, 2019
End-Stage Renal Disease-Associated Gut Bacterial Translocation: Evolution and Impact on Chronic Inflammation and Acute Rejection After Renal TransplantationClémence Carron, Jean-Paul Pais de Barros, Emilie Gaiffe, et al.
American Journal of Hematology|June 29, 2016
Health-related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of diseaseFabio Efficace, Franco Mandelli, Paola Fazi, et al.
Antimicrobial Agents and Chemotherapy|March 10, 2022
An Optimized Dihydrodibenzothiazepine Lead Compound (SBI-0797750) as a Potent and Selective Inhibitor of Plasmodium falciparum and P. vivax Glucose 6-Phosphate Dehydrogenase 6-PhosphogluconolactonaseIsabell Berneburg, Satyamaheshwar Peddibhotla, Kim C Heimsch, et al.
Leukemia|February 19, 2013
Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinibF Efficace, M Baccarani, M Breccia, et al.
Blood|July 14, 2011
Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general populationFabio Efficace, Michele Baccarani, Massimo Breccia, et al.
Haematologica|April 7, 2022
Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib: 10-year followup of the GIMEMA CML 0307 studyGabriele Gugliotta, Fausto Castagnetti, Massimo Breccia, et al.
Developmental Cell|December 5, 2018
AMBRA1 Controls Regulatory T-Cell Differentiation and Homeostasis Upstream of the FOXO3-FOXP3 AxisJuliane Becher, Luca Simula, Elisabetta Volpe, et al.
Nature Communications|May 16, 2024
TDP-43 proteinopathy in ALS is triggered by loss of ASRGL1 and associated with HML-2 expressionMarta Garcia-Montojo, Saeed Fathi, Cyrus Rastegar, et al.
The European Physical Journal. C, Particles and Fields|May 15, 2015
Review of lattice results concerning low-energy particle physics, S Aoki, Y Aoki, et al.
Advanced Healthcare Materials|June 26, 2024
Study of the Structure of Hyperbranched Polyglycerol Coatings and Their Antibiofouling and Antithrombotic ApplicationsEli Moore, Alexander J Robson, Amy R Crisp, et al.
Pageof 30

Showing results (281-290 of 296) with videos related to

Sort By:
Pageof 30
Frontiers in Immunology|September 3, 2019
End-Stage Renal Disease-Associated Gut Bacterial Translocation: Evolution and Impact on Chronic Inflammation and Acute Rejection After Renal TransplantationClémence Carron, Jean-Paul Pais de Barros, Emilie Gaiffe, et al.
American Journal of Hematology|June 29, 2016
Health-related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of diseaseFabio Efficace, Franco Mandelli, Paola Fazi, et al.
Antimicrobial Agents and Chemotherapy|March 10, 2022
An Optimized Dihydrodibenzothiazepine Lead Compound (SBI-0797750) as a Potent and Selective Inhibitor of Plasmodium falciparum and P. vivax Glucose 6-Phosphate Dehydrogenase 6-PhosphogluconolactonaseIsabell Berneburg, Satyamaheshwar Peddibhotla, Kim C Heimsch, et al.
Leukemia|February 19, 2013
Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinibF Efficace, M Baccarani, M Breccia, et al.
Blood|July 14, 2011
Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general populationFabio Efficace, Michele Baccarani, Massimo Breccia, et al.
Haematologica|April 7, 2022
Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib: 10-year followup of the GIMEMA CML 0307 studyGabriele Gugliotta, Fausto Castagnetti, Massimo Breccia, et al.
Developmental Cell|December 5, 2018
AMBRA1 Controls Regulatory T-Cell Differentiation and Homeostasis Upstream of the FOXO3-FOXP3 AxisJuliane Becher, Luca Simula, Elisabetta Volpe, et al.
Nature Communications|May 16, 2024
TDP-43 proteinopathy in ALS is triggered by loss of ASRGL1 and associated with HML-2 expressionMarta Garcia-Montojo, Saeed Fathi, Cyrus Rastegar, et al.
The European Physical Journal. C, Particles and Fields|May 15, 2015
Review of lattice results concerning low-energy particle physics, S Aoki, Y Aoki, et al.
Advanced Healthcare Materials|June 26, 2024
Study of the Structure of Hyperbranched Polyglycerol Coatings and Their Antibiofouling and Antithrombotic ApplicationsEli Moore, Alexander J Robson, Amy R Crisp, et al.
Pageof 30